Initial Results from Novavax' COVID-19-Influenza Vaccine Trial...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
GAITHERSBURG, Md., April 21, 2022 /PRNewswire-AsiaNet/ -- -- Phase 1/2 clinical trial of COVID-19-Influenza combination vaccine candidate indicates vaccine is well-tolerated and immunogenic-- Data from this combination trial will inform planned Phase 2 dose confirmation trial,...
Authors: LATEST ASIANET NEWS RELEASES